Bele Tanja, Fabbretti Elsa
Center for Biomedical Sciences and Engineering, University of Nova Gorica, Nova Gorica, Slovenia.
J Neurochem. 2016 Aug;138(4):587-97. doi: 10.1111/jnc.13680. Epub 2016 Jun 18.
P2X3 receptors, gated by extracellular ATP, are expressed by sensory neurons and are involved in peripheral nociception and pain sensitization. The ability of P2X3 receptors to transduce extracellular stimuli into neuronal signals critically depends on the dynamic molecular partnership with the calcium/calmodulin-dependent serine protein kinase (CASK). The present work used trigeminal sensory neurons to study the impact that activation of P2X3 receptors (evoked by the agonist α,β-meATP) has on the release of endogenous ATP and how CASK modulates this phenomenon. P2X3 receptor function was followed by ATP efflux via Pannexin1 (Panx1) hemichannels, a mechanism that was blocked by the P2X3 receptor antagonist A-317491, and by P2X3 silencing. ATP efflux was enhanced by nerve growth factor, a treatment known to potentiate P2X3 receptor function. Basal ATP efflux was not controlled by CASK, and carbenoxolone or Pannexin silencing reduced ATP release upon P2X3 receptor function. CASK-controlled ATP efflux followed P2X3 receptor activity, but not depolarization-evoked ATP release. Molecular biology experiments showed that CASK was essential for the transactivation of Panx1 upon P2X3 receptor activation. These data suggest that P2X3 receptor function controls a new type of feed-forward purinergic signaling on surrounding cells, with consequences at peripheral and spinal cord level. Thus, P2X3 receptor-mediated ATP efflux may be considered for the future development of pharmacological strategies aimed at containing neuronal sensitization. P2X3 receptors are involved in sensory transduction and associate to CASK. We have studied in primary sensory neurons the molecular mechanisms downstream P2X3 receptor activation, namely ATP release and partnership with CASK or Panx1. Our data suggest that CASK and P2X3 receptors are part of an ATP keeper complex, with important feed-forward consequences at peripheral and central level.
P2X3受体由细胞外ATP门控,由感觉神经元表达,参与外周伤害感受和疼痛敏化。P2X3受体将细胞外刺激转化为神经元信号的能力关键取决于与钙/钙调蛋白依赖性丝氨酸蛋白激酶(CASK)的动态分子伙伴关系。本研究使用三叉神经感觉神经元来研究P2X3受体激活(由激动剂α,β-甲基ATP诱发)对内源性ATP释放的影响以及CASK如何调节这一现象。通过Pannexin1(Panx1)半通道介导的ATP外流来追踪P2X3受体功能,该机制可被P2X3受体拮抗剂A-317491阻断,也可通过P2X3沉默来阻断。神经生长因子可增强ATP外流,已知该处理可增强P2X3受体功能。基础ATP外流不受CASK控制,而羧苄青霉素或Panx1沉默可减少P2X3受体功能时的ATP释放。CASK控制的ATP外流跟随P2X3受体活性,但不跟随去极化诱发的ATP释放。分子生物学实验表明,CASK对于P2X3受体激活后Panx1的反式激活至关重要。这些数据表明,P2X3受体功能控制着对周围细胞的一种新型前馈嘌呤能信号传导,在外周和脊髓水平都有影响。因此,P2X3受体介导的ATP外流可能被考虑用于未来旨在抑制神经元敏化的药理学策略的开发。P2X3受体参与感觉转导并与CASK相关联。我们在初级感觉神经元中研究了P2X3受体激活下游的分子机制,即ATP释放以及与CASK或Panx1的伙伴关系。我们的数据表明,CASK和P2X3受体是ATP保持复合物的一部分,在外周和中枢水平具有重要的前馈影响。